Inventor · disambiguated record
Bronislava Gedulin
Also filed as: GEDULIN BRONISLAVA
26 granted patents·25 pending applications·1,076 citations·filing 1997–2025
97Inventor score
Files withAMYLIN PHARMACEUTICALS INC11LUMENA PHARMACEUTICALS INC9SATIOGEN PHARMACEUTICALS INC8SHIRE HUMAN GENETIC THERAPIES6YOUNG ANDREW A5
Top patents by PatentIndex Score
51 records- 0198US7153825B2Methods for glucagon suppression using modified exendinsAMYLIN PHARMACEUTICALS INC·Filed 2005·Granted Dec 26, 2006·111 cites·35 claims
- 0298US6872700B1Methods for glucagon suppressionAMYLIN PHARMACEUTICALS INC·Filed 2000·Granted Mar 29, 2005·184 cites·24 claims
- 0398US6858576B1Methods for regulating gastrointestinal motilityAMYLIN PHARMACEUTICALS INC·Filed 1997·Granted Feb 22, 2005·211 cites·22 claims
- 0497US8288338B2Exendin and exendin agonists for eating disordersYOUNG ANDREW A·Filed 2010·Granted Oct 16, 2012·62 cites·20 claims
- 0597US8026210B2Exendins and exendin agonist analogs to regulate gastrointestinal motilityAMYLIN PHARMACEUTICALS INC·Filed 2009·Granted Sep 27, 2011·43 cites·21 claims
- 0697US7741269B2Exendins and exendin agonists for weight reduction and obesityAMYLIN PHARMACEUTICALS INC·Filed 2004·Granted Jun 22, 2010·88 cites·44 claims
- 0797US7521423B2Exendin pharmaceutical compositionsAMYLIN PHARMACEUTICALS INC·Filed 2004·Granted Apr 21, 2009·96 cites·32 claims
- 0897US7407932B2Methods for glucagon suppression using modified exendinsAMYLIN PHARMACEUTICALS INC·Filed 2006·Granted Aug 5, 2008·41 cites·7 claims
- 0997US7297761B2Pharmaceutical compositions containing exendinsAMYLIN PHARMACEUTICALS INC·Filed 2004·Granted Nov 20, 2007·114 cites·37 claims
- 1095US9339480B2Bile acid recycling inhibitors for treatment of obesity and diabetesYOUNG ANDREW A·Filed 2009·Granted May 17, 2016·38 cites·23 claims
- 1189US11229661B2Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseasesSHIRE HUMAN GENETIC THERAPIES·Filed 2019·Granted Jan 25, 2022·2 cites·17 claims
- 1289US8263554B2Methods of using GLP-1 receptor agonists to treat pancreatitisTATARKIEWICZ KRYSTYNA·Filed 2011·Granted Sep 11, 2012·18 cites·18 claims
- 1388US9345715B2Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereofSATIOGEN PHARMACEUTICALS INC·Filed 2012·Granted May 24, 2016·10 cites·11 claims
- 1488US8318663B2Methods of treating diabetes and/or obesity using an enteroendocrine peptide secretion enhancing agentYOUNG ANDREW A·Filed 2009·Granted Nov 27, 2012·9 cites·17 claims
- 1587US8481490B2Method of reducing plasma amylase and/or plasma lipase in patients with pancreatitisTATARKIEWICZ KRYSTYNA·Filed 2012·Granted Jul 9, 2013·14 cites·4 claims
- 1687US2025282808A1Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver diseaseSHIRE HUMAN GENETIC THERAPIES·Filed 2024·Application pending·0 cites
- 1786US11260053B2Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditionsSATIOGEN PHARMACEUTICALS INC·Filed 2019·Granted Mar 1, 2022·1 cites·21 claims
- 1886US10512657B2Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseasesLUMENA PHARMACEUTICALS LLC·Filed 2016·Granted Dec 24, 2019·6 cites·17 claims
- 1985US2025281482A1Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseasesSHIRE HUMAN GENETIC THERAPIES·Filed 2025·Application pending·0 cites
- 2082US12350267B2Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseasesSHIRE HUMAN GENETIC THERAPIES·Filed 2022·Granted Jul 8, 2025·0 cites·20 claims
- 2182US12145959B2Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver diseaseSHIRE HUMAN GENETIC THERAPIES·Filed 2022·Granted Nov 19, 2024·0 cites·21 claims
- 2280US10555950B2Bile acid recycling inhibitors for treatment of obesity and diabetesSATIOGEN PHARMACEUTICALS INC·Filed 2016·Granted Feb 11, 2020·2 cites·6 claims
- 2380US10251880B2Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditionsSATIOGEN PHARMACEUTICALS INC·Filed 2014·Granted Apr 9, 2019·3 cites·12 claims
- 2479US11376251B2Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseasesSHIRE HUMAN GENETIC THERAPIES·Filed 2021·Granted Jul 5, 2022·0 cites·19 claims
- 2578US10188646B2Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditionsGEDULIN BRONISLAVA·Filed 2012·Granted Jan 29, 2019·3 cites·15 claims
- 2677US2022362238A1Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditionsSATIOGEN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2766US2015080307A1Exendins and exendin agonist analogs to regulate gastrointestinal motilityAMYLIN PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 2863US2020207797A1Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver diseaseLUMENA PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 2963US2013023470A1Exendin and exendin agonists for eating disordersAMYLIN PHARMACEUTICALS LLC·Filed 2012·Application pending·0 cites
- 3062US2013338093A1Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver DiseasesLUMENA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3161US7101853B2Method for treating or preventing gastritis using amylin or amylin agonistsAMYLIN PHARMACEUTICALS INC·Filed 1997·Granted Sep 5, 2006·20 cites·26 claims
- 3261US2013109671A1Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver DiseasesLUMENA PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 3361US2017368085A1Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseasesLUMENA PHARMACEUTICALS LLC·Filed 2017·Application pending·0 cites
- 3461US2014243281A1Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseasesLUMENA PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 3560US2019169217A1Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver diseaseLUMENA PHARMACEUTICALS LLC·Filed 2018·Application pending·0 cites
- 3659US2014323412A1Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver diseaseLUMENA PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 3759US2013108573A1Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver DiseaseLUMENA PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 3858US2012004168A1Exendins and exendin agonist analogs to regulate gastrointestinal motilityYOUNG ANDREW A·Filed 2011·Application pending·0 cites
- 3957US8168233B2Treatment of pancreatitis with amylinGEDULIN BRONISLAVA·Filed 2003·Granted May 1, 2012·0 cites·13 claims
- 4057US2013331322A1Exendins and exendin agonist analogs to regulate gastrointestinal motilityASTRAZENECA PHARMACEUTICALS LP·Filed 2013·Application pending·0 cites
- 4154US10028952B2Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereofSATIOGEN PHARMACEUTICALS INC·Filed 2016·Granted Jul 24, 2018·0 cites·19 claims
- 4254US2011294767A1Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditionsGEDULIN BRONISLAVA·Filed 2011·Application pending·0 cites
- 4353US2012157399A1Bile acid recycling inhibitors for treatment of obesity and diabetesYOUNG ANDREW A·Filed 2012·Application pending·0 cites
- 4449US2006122106A1Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereofAMYLIN PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 4548US2007275877A1Methods for Treating or Ameliorating Ghrelin-Associated Diseases and DisordersAMYLIN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 4646US2015119345A1Bile acid recycling inhibitors for treatment of gastrointestinal infectionsLUMENA PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4743US2014271734A1Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux diseaseLUMENA PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4843US2014275090A1Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel diseaseLUMENA PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4942US2013034536A1Bile Acid Recycling Inhibitors for Treatment of PancreatitisLUMENA PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 5042US2013090590A1Methods and Apparatus for Treating Obesity and DiabetesSATIOGEN PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →